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Objective: Burkholderia cenocepacia (Bc) is a highly antimicrobially resistant
pathogen, which is rarely eradicated from cystic ﬁbrosis (CF) patients. While
Bc is generally conﬁned to the lung, bacteraemia can develop in a subgroup of
patients contributing to a sharp decline in health. How Bc chronically colonises
and causes bacteraemia remain poorly understood. Bacteria can change phenotype
during infection, adapting to the host environment. We aim to identify the alterations
in Bc phenotype from initial colonisation to chronic infection.
Methods: A series of genetically identical sequential Bc isolates from two siblings
with CF, one with chronic infection conﬁned to the lung (Pt1), the other with
bacteraemia (Pt2), were studied. In vivo virulence using Galleria mellonella,
mucoidy on yeast extract mannitol (YEM) agar and adhesion to CF lung epithelial
cells (CFBE41o−) were examined.
Results: All isolates were relatively avirulent in vivo in Galleria mellonella. The
blood isolates from Pt2 were considerably more virulent than a sputum isolate
from that patient (P = 0.014). Mucoid production by Bc has been associated with
better patient outcomes; however, all but one isolate were non-mucoid on YEM.
Both sputum and blood isolates increased attachment to CFBEs over time of
colonisation (p< 0.005 and 0.001 respectively), indicating an increased potential
for host epithelial interactions over time. This key adaptation was conﬁrmed by
confocal microscopy. We are currently comparing the proteomes of all isolates to
identify alterations in protein expression that may be involved.
Conclusions: It is clear that Bc adapts and increases virulence during colonisation.
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Objectives: Identiﬁcation of genetic markers for transformation of intermittently
colonizing P. aeruginosa (PA) to chronically infecting bacteria in CF lungs.
Methods: Clinical isolates of PA have been systematically collected for 10 years
from early infection stages in CF children and young adults. For this study, 34 pa-
tients and therefrom ca. 500 isolates were chosen for full genome sequencing. Based
on bioinformatics analyses, mutations accumulated during airway colonization were
listed and a number of repeated patho-adaptive mutations identiﬁed.
Results: Approximately 75% of all patients were colonised or infected with the
same clone type during the entire period of infection. Clones could be divided into
two groups: persisting and non-persisting with a median period of residence of
4.25 years and 1.7 years, respectively (p = 0.02). Among all sequenced genomes
we found 56 genes to be mutated more that 6 times suggesting a role in patho-
adaptation; however only 18 genes remained consistently mutated in the persisting
clones. These mutations mainly belong to: Envelope, Antibiotic Resistance, and
Iron acquisition. We compared the time of appearance of mutations to colonisation
time in persistent and non-persistent clones and found no signiﬁcant difference
between the two groups (p = 0.7).
Conclusion: Despite intensive antibiotic chemotherapy whenever PA is cultured
from the CF lung, the bacteria are only eradicated in few patients. We think that
adaptation probably happens before PA has established high enough densities in the
lungs to be cultured from sputum or endolaryngeal suctions.
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Pseudomonas aeruginosa clones C and PA14 are the two most prevalent clones in
the bacterial population in both environment and disease habitats including cystic
ﬁbrosis (CF) lungs. Since no whole genome sequence of any clone C isolate is
yet available, we sequenced the CF isolate NN2 as the future reference genome
of P. aeruginosa clone C. The 6.9 Mb large genome was characterized in its
genetic repertoire of protein-coding ORFs and of non-coding RNAs. To analyze the
worldwide genomic diversity within these two clones, we sequenced the genomes
of 58 clone C and 42 clone PA14 isolates from environment, acute infections and
chronic airway infections in individuals with COPD or CF. The individual strains
differ in the repertoire of the accessory genome and a median sequence diversity
of 0.02% or 0.003% from each other. Protein variants with non-conservative
amino acid substitutions were predominantly seen in elements of horizontal gene
transfer and transporters and enzymes encoded by cargo region of the accessory
genome indicating diversifying selection. Functional protein variants were very
rare in the core genome in all strains but isolates from CF lungs. The CF strains
accumulated pathoadaptive mutations in major regulators of the bioﬁlm lifestyle
and pilus and exopolysaccharide biogenesis genes indicating positive selection in
loci that facilitate persistence in CF airways. Clone C or clone PA14 isolates of
matching pyocin and antitoxin capabilities were tested for their competitive ﬁtness in
planctonic cultures for ﬁve days. The CF isolates were not signiﬁcantly impaired in
persistence compared to isolates from acute infections or inanimate aquatic habitats.
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Objectives: It is well documented that P. aeruginosa adapts to CF airways, but little
is known of the selective pressures that drive this evolution. Through an extensive
collection of 474 whole-genome sequences from clinical P. aeruginosa isolates, we
have identiﬁed longitudinally sequential mutations in the RetS/GacA/GacS/RsmA
regulatory system. This system reciprocally regulates genes responsible for directing
the bacteria towards either acute or chronic lung infection pathways. RetS represses
the effect of GacA, a transcriptional activator of the sRNAs, RsmY and RsmZ.
These sRNAs, when expressed, sequester the transcriptional regulator, RsmA. RsmA
activates expression of acute infection genes and represses transcription of chronic
infection genes. The goal of the study is to gain insights into the adaptation of the
isolates.
Methods: Using a global -omics approach, we have investigated the effects of
these sequential mutations in eight isolates belonging to two clone types in order
to characterize the resulting phenotypes associated with the different regulatory
mutations.
Results: The ﬁrst mutation occurs in retS, leading to a chronic infection phenotype.
This mutation is followed up by a mutation in gacA or gacS, which may revert
the effect of the retS mutation or lead to a new phenotype. Transcriptomics,
proteomics, and metabolomics data will be presented to characterize the adaptational
phenotypes.
Conclusion: The results of the investigation will be presented with the aim of
understanding how the mutations may promote a progression of the infection by
changing the regulation of the RetS–GacAS regulatory network caused by selective
pressure of the CF airways.
